MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

Topic

January 22, 2015

NEW YORK/PARIS—A hospital operated by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) was directly targeted in an aerial bombing in Sudan on January 20, forcing the suspension of medical activities, MSF announced today.

January 22, 2015

MSF Public Health Specialist Dr. Armand Sprecher describes MSF’s clinical protocols, challenges faced, and lessons learned during the largest-ever outbreak of Ebola in West Africa.

January 21, 2015

Before joining the Doctors Without Borders/Médecins Sans Frontières (MSF) Ebola emergency mission in Liberia in August 2014, Liberian physician's assistant Jackson K.P. Naimah worked as a vaccine officer in Liberia’s Ministry of Health and Social Welfare. Here, he tells his story.

January 20, 2015

Tens of thousands of people in Myanmar’s Rakhine state are able to access basic health care and emergency referral from medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) for the first time in over nine months. Following instructions to MSF Holland to cease activities last February, these primary health clinics restarted on December 17, 2014. 

January 20, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) today called on pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer to slash the price of the pneumococcal vaccine to US$5 per child in developing countries, ahead of a major vaccination donor conference in Berlin.

January 16, 2015

Vaccination is a cornerstone of Doctors Without Borders/Médecins Sans Frontières’ (MSF) work to reduce illness and death caused by preventable diseases. While global immunization coverage reached 84 percent in 2013, in some places vaccination rates have stagnated, leaving behind children chronically unimmunized and unprotected. For more than 40 years, MSF has been at the forefront of vaccine delivery in crisis contexts, and in response to outbreaks of vaccine-preventable diseases. We also conduct routine immunization in areas where health systems have failed.

January 16, 2015

Up to 20,000 people in the southern tip of Malawi, the area most affected by current flooding, remain cut off from the rest of the country without food, health care, or means to prevent possible disease outbreaks.

January 15, 2015

Doctors Without Borders/Médecins Sans Frontières (MSF) clinical psychologist Hélène Thomas carried out two assignments in Central African Republic (CAR) between April and December 2014 and opened MSF’s program of medical and psychological support for victims of sexual violence (VSV) at the general hospital in Bangui, CAR’s capital.

Again and again, she heard the testimonies of people imprisoned by violence and trauma.

January 15, 2015

Thousands of IDPs seeking refuge in the Kurdistan Regional Government of Iraq have now settled in Dohuk governorate, where four MSF teams are providing care for the most vulnerable people.

January 14, 2015

The Indian Patent Controller today rejected one of Gilead’s key patent applications, which covered the drug sofosbuvir, used to treat hepatitis C (HCV). The oral drug, which first received regulatory approval in the US in November 2013, and has been priced by Gilead at US$84,000 for a treatment course, or $1,000 per pill in the US, has caused a worldwide debate on the pricing of patented medicines. A study from Liverpool University showed that sofosbuvir could be produced for as little as $101 for a three-month treatment course.

Pages